The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy.

Deniz Can GuvenGozde KavgaciOktay Halit AktepeHasan C YildirimTaha Koray SahinSercan AksoyMustafa ErmanSaadettin KilickapSuayib Yalcin

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

In this study, we observed a high rate of polypharmacy and inappropriate prescription practices in ICI-treated patients. These issues pointed out the need for improved general medical care and attention for better comedication management in ICI-treated patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
healthcare
prognostic factors
primary care
physical activity
patient reported outcomes
adverse drug
papillary thyroid
drug induced
community dwelling